| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Sep 16, 2024 | Inmune Bio, Inc. | CEO | Buy | 72.5 | +15,380 | 1.00% | ✗ | $98K |
| Apr 19, 2024 | Apr 24, 2024 | Inmune Bio, Inc. | CEO | Buy | 82.5 | +18,028 | 1.19% | ✗ | $150K |
| May 26, 2022 | May 31, 2022 | Inmune Bio, Inc. | CEO | Buy | 61.3 | +6,300 | 0.42% | ✗ | $40.4K |
| Nov 3, 2021 | Nov 4, 2021 | Inmune Bio, Inc. | CEO | Sell | 50.0 | -3,626 | -0.24% | ✓ | $72.5K |
| Oct 27, 2021 | Oct 29, 2021 | Inmune Bio, Inc. | CEO | Sell | 48.8 | -6,517 | -0.43% | ✓ | $130.3K |
| Oct 22, 2021 | Oct 26, 2021 | Inmune Bio, Inc. | CEO | Sell | 42.5 | -23,616 | -1.55% | ✓ | $472.3K |
| Jul 7, 2021 | Jul 9, 2021 | Inmune Bio, Inc. | CEO | Sell | 42.5 | -30,000 | -1.95% | ✓ | $602K |
| Aug 20, 2019 | Aug 21, 2019 | Inmune Bio, Inc. | CEO | Buy | 56.3 | +2,000 | 0.13% | ✗ | $12K |
| Aug 9, 2019 | Aug 12, 2019 | Inmune Bio, Inc. | CEO | Buy | 56.3 | +2,000 | 0.13% | ✗ | $14.1K |
| Jun 3, 2019 | Jun 4, 2019 | Inmune Bio, Inc. | CEO | Buy | 72.5 | +10,000 | 0.65% | ✗ | $60K |
| May 2, 2019 | May 20, 2019 | Inmune Bio, Inc. | CEO | Buy | 72.5 | +11,100 | 0.73% | ✗ | $119.3K |
| May 2, 2019 | May 9, 2019 | Inmune Bio, Inc. | CEO | Buy | 72.5 | +11,100 | 0.73% | ✗ | $99.9K |
| May 2, 2019 | May 6, 2019 | Inmune Bio, Inc. | Chair | Buy | 72.5 | +11,100 | 0.73% | ✗ | $109.9K |